Single nucleus RNA sequencing unveils relationship between microglia and endothelial cells in mixed Alzheimer's disease and vascular pathology. [PDF]
Olayinka OA +10 more
europepmc +1 more source
Review of Pierre Larrivée (2001) L’interprétation des séquences négatives: portée et foyer des négations en français. (Champs linguistiques. Brussels: Duculot.) [PDF]
Rowlett, P
core +2 more sources
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Feasibility of a Study Within a Trial to evaluate a decision support intervention for families deciding about research on behalf of adults lacking capacity to consent (CONSULT SWAT). [PDF]
Shepherd V +7 more
europepmc +2 more sources
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Zosteriform Primary Cutaneous Marginal Zone Lymphoma-A Case Report. [PDF]
Teh N +4 more
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Japanese Negative Polarity Items and Negative Concord
text
openaire
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Prognosis of patients hospitalised with primary or secondary pericardial disease: an Australian population-based retrospective cohort study. [PDF]
Kwan TN +6 more
europepmc +1 more source

